Inspire Investing LLC Lowers Stock Position in Plexus Corp. (NASDAQ:PLXS)

Inspire Investing LLC trimmed its position in Plexus Corp. (NASDAQ:PLXS) by 11.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,021 shares of the technology company’s stock after selling 395 shares during the quarter. Inspire Investing LLC’s holdings in Plexus were worth $413,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quest Partners LLC boosted its position in shares of Plexus by 36,700.0% in the second quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock worth $38,000 after purchasing an additional 367 shares during the period. Innealta Capital LLC bought a new position in Plexus in the 2nd quarter worth $51,000. GAMMA Investing LLC increased its stake in Plexus by 190.1% in the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock worth $104,000 after buying an additional 498 shares in the last quarter. EntryPoint Capital LLC raised its holdings in Plexus by 56.2% during the first quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after acquiring an additional 351 shares during the period. Finally, Signaturefd LLC lifted its position in shares of Plexus by 12.0% in the second quarter. Signaturefd LLC now owns 1,705 shares of the technology company’s stock valued at $176,000 after acquiring an additional 183 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Insider Transactions at Plexus

In related news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $128.02, for a total value of $64,010.00. Following the completion of the transaction, the director now owns 9,586 shares of the company’s stock, valued at approximately $1,227,199.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Steven J. Frisch sold 6,565 shares of the stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total transaction of $841,042.15. Following the sale, the insider now owns 36,118 shares in the company, valued at approximately $4,627,076.98. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction on Friday, August 30th. The stock was sold at an average price of $128.02, for a total transaction of $64,010.00. Following the transaction, the director now directly owns 9,586 shares of the company’s stock, valued at $1,227,199.72. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,113 shares of company stock worth $2,541,394 in the last three months. Insiders own 2.39% of the company’s stock.

Plexus Price Performance

Shares of Plexus stock opened at $138.07 on Thursday. The firm has a market cap of $3.78 billion, a PE ratio of 38.14 and a beta of 0.89. The stock has a 50 day moving average of $127.85 and a 200 day moving average of $114.02. The company has a current ratio of 1.47, a quick ratio of 0.64 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 12 month low of $87.21 and a 12 month high of $139.04.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, July 24th. The technology company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.17. Plexus had a return on equity of 9.64% and a net margin of 2.82%. The firm had revenue of $960.70 million during the quarter, compared to the consensus estimate of $981.32 million. During the same period in the prior year, the company earned $1.32 EPS. The company’s quarterly revenue was down 6.0% compared to the same quarter last year. On average, research analysts expect that Plexus Corp. will post 3.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on PLXS shares. Needham & Company LLC lifted their target price on Plexus from $114.00 to $144.00 and gave the company a “buy” rating in a research note on Friday, July 26th. Benchmark increased their price objective on shares of Plexus from $145.00 to $150.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Plexus has an average rating of “Moderate Buy” and an average target price of $125.25.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.